New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 26, 2012
10:00 EDTMYL, CME, ACAT, OI, HBAN, AB, LAZ, TGT, STEL, EXPE, PG, PSXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AllianceBernstein (AB) upgraded to Equal Weight from Underweight at Morgan Stanley... CME Group (CME) upgraded to Outperform from Market Perform at Raymond James... Expedia (EXPE) upgraded to Buy from Hold at Benchmark Co.... Expedia (EXPE) upgraded to Outperform from Market Perform at Raymond James... Huntington Bancshares (HBAN) upgraded to Buy from Neutral at Citigroup... Mylan (MYL) upgraded to Buy from Hold at Canaccord... StellarOne (STEL) upgraded to Strong Buy from Outperform at Raymond James... Owens-Illinois (OI) upgraded to Buy from Neutral at BofA/Merrill... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Target (TGT) upgraded to Buy from Neutral at Buckingham... Arctic Cat (ACAT) upgraded to Strong Buy from Buy at Felti... Proctor and Gamble (PG) upgraded to Outperform from Underperform at CLSA... Lazard (LAZ) upgraded to Neutral from Sell at Rochdale.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 2, 2015
09:18 EDTPGFutureFuel upgraded to Buy on raised 2016 visibility at Roth Capital
Roth Capital analyst Craig Irwin upgraded FutureFuel (FF) to Buy saying the renewal of a bleach activator supply agreement with Procter & Gamble (PG) raises visibility for 2016. He raised his price target for shares to $13 from $12.
08:21 EDTTGTAmazon to be number two player in U.S. consumables by 2018, says Cowen
John Blackledge and the research team at Cowen project that (AMZN) will grow to be the number two player in the $425B market for U.S. consumables - which they define as personal care, household, pet and baby products - by 2018. The firm expects Amazon to use its multi-platform approach, centered around Prime, to help the e-commerce giant gain share in consumables at the expense of Wal-Mart (WMT), Target (TGT), Walgreens (WBA) and CVS Health (CVS). Cowen has Outperform ratings on Amazon and Target and a Market Perform rating on shares of Wal-Mart.
07:31 EDTCMECME Group averaged 14.4M contracts per day in Q3
CME Group announced that September volume averaged 14.1M contracts per day, down 7% from September 2014. Total volume was more than 296M contracts, of which 87% was traded electronically. Average daily volume to date in 2015 is 14.2 million contracts, up 7 percent versus the same period in 2014, with year-over-year growth across all six product lines. CME Group interest rate volume averaged 6.2 million contracts per day in September 2015, down 23 percent compared with September 2014. Treasury futures volume averaged 2.3 million contracts per day, down 21 percent from the same period a year ago. Treasury options volume was down 24 percent at more than 515,000 contracts per day. Eurodollar futures volume averaged 2.3 million contracts per day, down 30 percent compared with September 2014. Eurodollar options volume averaged 966,000 contracts per day, down 22 percent in September, with 20 percent of the Eurodollar options volume traded electronically.
October 1, 2015
16:05 EDTPGFutureFuel extends supply agreement with Procter & Gamble
Subscribe for More Information
09:12 EDTEXPEUBS internet and leisure analysts hold an analyst/industry conference call
Internet Analyst Sheridan and Leisure Analyst Farley, along with Max Starkov, the CEO of HeBS Digital, discuss the mechanics of instant booking on Google and TripAdvisor, the pros and cons of these programs from a hotelier's perspective and what impact Google and TripAdvisor's instant booking programs will have on Expedia and on an Analyst/Industry conference call to be held on October 1 at 10:30 am.
06:03 EDTEXPEPriceline has best risk/reward in online travel, says Piper Jaffray
Piper Jaffray analyst Michael Olson says Priceline (PCLN) has the most favorable risk/reward in the online travel space given its "attractive" valuation and exposure to broad strength in Europe. Travel industry trends in Europe during Q3 indicate a solid quarter while U.S. trends showed mixed results, Olson tells investors in a research note. He believes the recent selloff in Priceline presents an attractive entry point. The analyst reiterates Overweight ratings on Priceline, HomeAway (AWAY) and TripAdvisor (TRIP). Olson keeps a Neutral rating on Expedia (EXPE) saying the valuation "appears full" compared to peers.
05:23 EDTPSXPhillips 66, Energy Transfer, Sunoco Logistics begin open season for BBP
Subscribe for More Information
September 30, 2015
14:58 EDTMYLMylan volatility at 52-week high
Mylan October weekly put option implied volatility is at 70, October is at 57, November is at 54; compared to its 52-week range of 26 to 58, suggesting large price movement.
12:00 EDTTGTTarget management to meet with Jefferies
Meeting to be held in New York on October 5 hosted by Jefferies.
11:13 EDTTGTTarget announces expansion of price matching policy
Subscribe for More Information
11:06 EDTMYLStocks with call strike movement; FSLR MYL
First Solar (FSLR) January 50 call option implied volatility decreased 5% to 47, Mylan (MYL) January 47 call option implied volatility increased 4% to 48 according to IVolatility.
07:18 EDTABSecurities Industry and Financial Markets Association to hold a forum
Subscribe for More Information
September 29, 2015
12:35 EDTPG, MYLPerrigo shareholders pressure company to explore sale, Reuters says
Certain Perrigo (PRGO) shareholders have requested that company explore a sale, hoping for an alternative to Mylan's (MYL) approximately $25B hostile bid, Reuters reports, citing people familiar with the matter. The pressure represents a challenge to Perrigo's defense strategy, the report says. Some of the company's shareholders view Novartis (NVS), Sanofi (SNY), Procter & Gamble (PG), and Colgate-Palmolive (CL) as potential suitors, the report says. Reference Link
07:11 EDTTGTWal-Mart expands pick-up service to new markets, Fortune says
Subscribe for More Information
September 28, 2015
19:57 EDTTGTRetailers urge courts to reject Visa, MasterCard settlement, Reuters says
Subscribe for More Information
07:31 EDTMYLMylan launches generic Invega tablets
Subscribe for More Information
07:27 EDTMYLFDA and the Parental Drug Association to co-host a conference
Subscribe for More Information
06:42 EDTTGT, PGPerfume makers look to Wal-Mart, Target, WSJ reports
Subscribe for More Information
September 25, 2015
13:51 EDTMYLBMO's pharma predictions for rest of year include take on Mylan, Perrigo
BMO Capital analyst David Maris rolled out his rest of year predictions for the Specialty Pharmaceuticals space. Among them is his belief that Mylan (MYL) will be unsuccessful in acquiring Perrigo (PRGO). Perrigo will either be acquired by another company or make an acquisition itself, Maris tells investors in a research note. His other predictions include Jazz Pharmaceuticals (JAZZ) proving to be a good buying opportunity amidst the current negative sentiment and ZS Pharma (ZSPH) offering upside following the recent pullback given the potential for a near-term buyout and prospects for its "best in class drug for hyperkalemia" winning approval in 2016.
10:22 EDTCMECME Group, CFETS sign cooperation agreement
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use